For more than three decades, it has been known that the plasma kallikrein/k
inin system becomes activated when exposed to artificial, negatively charge
d surfaces. The existence of an encompassing in vivo, negatively charged su
rface capable of activation of the plasma kallikrein/kinin system has, howe
ver, never been convincingly demonstrated. in this report, we describe curr
ent knowledge on how the proteins of the plasma kallikrein/kinin system ass
emble to become activated on cell membranes. On endothelial cells, the acti
vation of the plasma kallikrein/kinin system is not initiated by factor XII
autoactivation as seen on artificial surfaces. On endothelial cells, preka
llikrein is activated by an antipain sensitive protease. Prekallikrein acti
vation is dependent on the presence of high molecular weight kininogen and
an optimal free Zn2+ concentration, Kallikrein generated on the surface of
endothelial cell is capable of activating factor XII. Further, kallikrein f
ormed on endothelial cell membranes is capable of cleaving its receptor and
native substrate, high molecular weight kininogen, liberating bradykinin a
nd the HK.PK complex from the endothelial cell surface. Endothelial cell-as
sociated kallikrein also is capable of kinetically favorable pro-urokinase
and, subsequent, plasminogen activation. (C) 1999 Elsevier Science B.V. All
rights reserved.